BCP Partnering Portal / CLONEGENE LLC
More Information on 'CLONEGENE LLC'
CLONEGENE LLC - Manufacturer based in CT, United States of America
CLONEGENE LLC is a company that specializes in designing and producing anti-peptide antibodies using proprietary software, ensuring an advanced understanding of the target epitope. The company's monoclonal antibodies perform well in all applications, and its products and services include monoclonal antibodies and recombinant proteins relevant to immunology, oncology, and virology. CLONEGENE LLC's reagents are used in both basic science research and clinical diagnostics, as well as therapeutics, and the company is committed to delivering high-quality reagents to biomedical researchers.
Announcements
A new recombinant anti-flu monoclonal RHB65 is available for distribution or license
Product Types:
Reagents & Kits
Industries:
Pharma & Biotech
Products, Services & Applications:
Antibodies
Verified Member
The BCP Partnering Portal
Where Manufacturers and Channel Partners / Distributors find each other!
- The BCP Partnering Portal is a specialized matchmaking platform featuring around 28,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
- Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 22 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
- This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
- Take advantage of this resource and join to manage your own company profile and search for new partners.
Opens Keyword Search with this company's main keywords and company type already chosen, leaving the company itself out. Add or remove choices to widen or narrow the list; Premium members, then the companies that share the most keywords, are listed first.